Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: Febrifugine Derivatives Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: CYCLOHEXYL ACID TRIAZOLE AZOLES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY DEVICE Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: ASSAY TO DETERMINE IN VIVO RECEPTOR OCCUPANCY Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: ANTI-CD27 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: SPIROHEPTANYL HYDANTOINS AS ROCK INHIBITORS Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: COMBINATORIAL DRUG DELIVERY DEVICE Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANTICANCER COMBINATION THERAPY WITH CD73 ANTAGONIST ANTIBODY AND PD-1/PD-L1 AXIS ANTAGONIST ANTIBODY Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: OXIME ETHER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ALKYLPHENYL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: PHENYLACETAMIDES AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: 5-MEMBERED AND BICYCLIC HETEROCYCLIC AMIDES AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: USES OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: Anti-LAG-3 Antibodies to Treat Hematological Malignancies Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: METHODS OF AAV THERAPY Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: METHODS OF PURIFYING PROTEINS USING CHROMATOGRAPHY Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: FEBRIFUGINE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING Filling date: 6 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: METHODS OF TREATMENT USING CTLA4 MOLECULES Filling date: 6 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHE- NYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: MODIFIED FIBROBLAST GROWTH FACTOR 21 (FGF-21) FOR USE IN METHODS FOR TREATING NONALCOHOLIC STEATOHEPATITIS (NASH) Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: METHODS OF TREATING TUMOR Filling date: 6 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: COMPOUNDS USEFUL AS IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: CYCLOHEXYL ACID PYRAZOLE AZINES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: Pyrazole N-Linked Carbamoyl Cyclohexyl Acids as LPA Antagonists Filling date: 6 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: PROCESS FOR PREPARING TETRAHYDROCARBAZOLE CARBOXAMIDE COMPOUND Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: CYCLOHEXYL ACID PYRAZOLE AZOLES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: NON-CHROMATOGRAPHIC PURIFICATION OF MACROCYCLIC PEPTIDES BY A RESIN CATCH AND RELEASE Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ARYL HETEROCYCLIC PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: FIBRONECTIN TYPE III DOMAIN PROTEINS WITH ENHANCED SOLUBILITY Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: SUBSTITUTED INDOLE ETHER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR DEUTERATED BIOLOGICS Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: ANTIBODIES TO CD40 Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: USE OF CAPRYLIC ACID PRECIPITATION FOR PROTEIN PURIFICATION Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: MACROCYCLIC TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Showing 150 to 200 of 438 patents.